Psychiatrists say that research into medications to treat mental health disorders, which affect almost a quarter of the US population, has slowed as major pharmaceutical companies cut back investment in this area. "The companies seem to have concluded that developing new psychiatric drugs is too risky and too expensive," said Richard Friedman, professor of clinical psychiatry at Weill Cornell Medical College in New York. The pullback came after a series ...
Read MoreYou have just read an article categorized health
titled As Investment Shrinks Research Slows on Mental Health Drugs Slows Down.
Written by:
editor - Wednesday, November 27, 2013
There are currently no comments for "As Investment Shrinks Research Slows on Mental Health Drugs Slows Down"
Post a Comment